Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SUN PHARMA ALKEM LABORATORIES/
SUN PHARMA
 
P/E (TTM) x 29.6 52.6 56.3% View Chart
P/BV x 4.6 4.5 101.8% View Chart
Dividend Yield % 1.0 1.1 92.5%  

Financials

 ALKEM LABORATORIES   SUN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
SUN PHARMA
Mar-22
ALKEM LABORATORIES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs4,068931 437.0%   
Low Rs2,671593 450.8%   
Sales per share (Unadj.) Rs889.4161.1 552.0%  
Earnings per share (Unadj.) Rs140.514.2 990.0%  
Cash flow per share (Unadj.) Rs166.023.1 717.5%  
Dividends per share (Unadj.) Rs34.0010.00 340.0%  
Avg Dividend yield %1.01.3 76.9%  
Book value per share (Unadj.) Rs722.4200.1 361.0%  
Shares outstanding (eoy) m119.572,399.34 5.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.84.7 80.1%   
Avg P/E ratio x24.053.7 44.7%  
P/CF ratio (eoy) x20.332.9 61.6%  
Price / Book Value ratio x4.73.8 122.5%  
Dividend payout %24.270.4 34.3%   
Avg Mkt Cap Rs m402,8681,827,693 22.0%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62773,008 26.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342386,545 27.5%  
Other income Rs m1,62714,374 11.3%   
Total revenues Rs m107,968400,919 26.9%   
Gross profit Rs m20,38053,150 38.3%  
Depreciation Rs m3,04021,437 14.2%   
Interest Rs m5241,274 41.1%   
Profit before tax Rs m18,44344,813 41.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,64010,755 15.2%   
Profit after tax Rs m16,80334,058 49.3%  
Gross profit margin %19.213.7 139.4%  
Effective tax rate %8.924.0 37.0%   
Net profit margin %15.88.8 179.3%  
BALANCE SHEET DATA
Current assets Rs m84,354350,150 24.1%   
Current liabilities Rs m48,053172,006 27.9%   
Net working cap to sales %34.146.1 74.1%  
Current ratio x1.82.0 86.2%  
Inventory Days Days42149 28.2%  
Debtors Days Days65100 64.7%  
Net fixed assets Rs m43,245318,882 13.6%   
Share capital Rs m2392,399 10.0%   
"Free" reserves Rs m86,134477,713 18.0%   
Net worth Rs m86,373480,112 18.0%   
Long term debt Rs m942,299 4.1%   
Total assets Rs m127,599669,032 19.1%  
Interest coverage x36.236.2 100.1%   
Debt to equity ratio x00 22.7%  
Sales to assets ratio x0.80.6 144.2%   
Return on assets %13.65.3 257.1%  
Return on equity %19.57.1 274.2%  
Return on capital %21.99.6 229.6%  
Exports to sales %18.70-   
Imports to sales %00-   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,924106,331 18.7%   
Fx outflow Rs m3,91171,874 5.4%   
Net fx Rs m16,01334,456 46.5%   
CASH FLOW
From Operations Rs m11,11089,845 12.4%  
From Investments Rs m-14,351-57,247 25.1%  
From Financial Activity Rs m3,796-51,935 -7.3%  
Net Cashflow Rs m580-17,648 -3.3%  

Share Holding

Indian Promoters % 57.1 54.5 104.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.8 34.6 57.1%  
FIIs % 5.7 15.0 37.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 45.5 94.2%  
Shareholders   84,104 647,167 13.0%  
Pledged promoter(s) holding % 0.0 4.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    


More on ALKEM LABORATORIES vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Sun Pharma Share Price Performance

Period ALKEM LABORATORIES Sun Pharma S&P BSE HEALTHCARE
1-Day 0.20% -0.06% 0.69%
1-Month 13.21% 2.18% 0.17%
1-Year -17.57% 17.56% -12.11%
3-Year CAGR 19.52% 30.69% 21.50%
5-Year CAGR 12.46% 12.63% 11.33%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.1% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

SGX Nifty Down 160 Points, NITI Aayog's EV Financing Push, Adani Group's Massive Investment on New Energy, and Top Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets swung between gains and losses throughout the session to end on a flat note.